D D Laxson

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans.

Robert F. Wilson, Betsy V. Christensen, M. T. Olivari et al. · Circulation · 1991 · 261 citations · Full text

Medicine, Cardiology, Physiology +10

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

Medicine, Cardiology, Pharmacology +17

Regional differences in sympathetic reinnervation after human orthotopic cardiac transplantation.

Robert F. Wilson, D D Laxson, Betsy V. Christensen et al. · Circulation · 1993 · 122 citations · Full text

Medicine, Cardiology, Surgery +13

Oxygen consumption and coronary reactivity in postischemic myocardium.

D D Laxson, David C. Homans, X Z Dai et al. · Circulation Research · 1989 · 96 citations · Full text

Medicine, Cardiology, Physiology +16